RET and neoplasm: NVP-AST487 treatment blocked Ret activity, as shown by the decreased pY1062 Ret levels in comparison to control tumour lysates (Fig 5D, upper panel) and had a significant inhibitory effect on tumour outgrowth (Fig 5C, red line).